Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
about
Unmet Needs in LDL-C Lowering: When Statins Won't Do!Triglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseStatin use in prediabetic patients: rationale and results to dateProfile of evolocumab and its potential in the treatment of hyperlipidemiaCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewPCSK9 Inhibition With Monoclonal Antibodies: Modern Management of HypercholesterolemiaShort-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation ParameterHypertriglyceridemia: the importance of identifying patients at risk.LDL-Cholesterol: Standards of Treatment 2016: A German Perspective.Pitavastatin and carbohydrate metabolism: what is the evidence?Cardiovascular Disease in Women: Clinical Perspectives.Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.Statins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.A Case of Statin-Associated Autoimmune MyopathyRole of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet-Induced Hypercholesterolemia and Hepatic Lipid Accumulation.Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysisStatin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.Genetics of cardiovascular disease: Importance of sex and ethnicity.Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients.Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study.Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint DiseasesTreatment Options for Statin-Associated Muscle Symptoms.Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data.Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational StudiesA Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice.Statins Impede a Healthy LifestyleTriglyceride and cardiovascular risk: A critical appraisal.Cholesterol trials and mortality.Statin use and all-cancer survival: prospective results from the Women's Health Initiative.Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells.Safety of atorvastatin in Asian patients within clinical trials.PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based studyThe German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.
P2860
Q26741705-2F508D6B-5A10-4E7D-A56B-2EDB9B39C74BQ26745946-FF3F88DE-71B5-49D2-A961-D04D541556F5Q26786008-ED525E86-8128-4DBF-BF7E-DED7230A3C87Q27004235-1BA90D2E-46B8-49F3-9C19-CD8DF084C399Q28076346-72C2D1A1-6380-48C6-8D6E-D18301D53899Q28275648-9AD443C0-B109-4881-804E-2FAB665E1076Q28831365-83148F9C-6195-41E2-BF41-8D4DE45A3256Q30244825-307676DE-29EA-440D-A0F5-353298D164B5Q30248925-50F30214-FAD2-4DF0-BDBE-2FC0912081FCQ30251801-1146C682-6094-43CC-9AFE-18596D73E5A9Q30743765-3067226E-C74F-49EA-9C84-D84F16111566Q31105715-1B9A18CE-F304-49C1-B2B2-3B1DB83F6224Q31133434-48410386-FCFB-4C48-B1DC-B1C950080F24Q33584194-8A8A1A87-FE54-4FDC-A400-43F112AD52CBQ33650363-B9D4A74C-3B67-4B5F-81D9-C6507BCA6D65Q33814374-100D63B6-753D-4A1D-82C7-6AB3903D7886Q33830394-3DC4B60C-86AF-476A-929F-352EB7694FA6Q35738812-9C710776-5C8E-402C-A61F-D576249A9803Q35886333-FBFE4244-2E67-4239-B75B-A391A61CE0AEQ36082805-0B007B36-8D0D-4602-820C-C080AAD0764EQ36260050-B882095B-49D7-400E-ADEF-25DA2ADD3D3BQ36265758-0783C583-845A-445C-9C5F-116FA3EBC760Q36294394-41D3E028-19D3-42E1-9C30-F88BE1C6F1C6Q36411986-139F50E4-79ED-40BC-81F7-53B52B6A105EQ36479927-8D477951-80EB-4387-B9CC-F8C021F324B9Q36543436-DAF04E6F-289A-4522-AFA4-F004BA2656F0Q36923769-C93037B7-928A-436C-86EC-DC6A3F807B33Q36996761-1B501BB4-575E-4E76-B891-45E30E72FAD8Q37015549-A34F4F32-A1F0-4CC1-925E-EDE0BA3EB488Q37030666-D87F4BB7-D5D9-418C-9DCE-AAED6487486CQ37061345-AB09D72D-53E8-4DE2-818A-9F70A6401971Q37101312-679E5F2E-6E1C-41A0-8615-3924C5A969B1Q37456623-E919775A-A10A-44CE-AAAF-F657FAEB6B1EQ37549374-C6DE9975-282A-4038-82E9-425E46EA1958Q37685518-7B28CAFC-2097-467E-A4E8-11D3C1936B4BQ37695071-BAF30FF5-D6E3-4237-836C-8B0D8160E99AQ37703258-8AAAD6E4-9844-48FD-96F8-AB062586B9D6Q37744428-26AB4E2C-596E-40CA-88DE-4FC030BA10C3Q38374348-B334F8C3-FD30-4ABA-9C78-6A5149838B35Q38380488-8A771EBC-D0D8-4F7B-B069-F2A766DD14B8
P2860
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@ast
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@en
type
label
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@ast
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@en
prefLabel
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@ast
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@en
P2093
P50
P1433
P1476
Efficacy and safety of LDL-low ...... pants in 27 randomised trials.
@en
P2093
Adrienne Kirby
Anthony Keech
Barry Davis
Cholesterol Treatment Trialists' (CTT) Collaboration
Colin Baigent
John La Rosa
John Simes
Jordan Fulcher
Lisa Blackwell
Maria Grazia Franzosi
P304
P356
10.1016/S0140-6736(14)61368-4
P407
P577
2015-01-09T00:00:00Z